« Return to News | CROs/Service Providers

CWWeekly April 21st 2008 Issue

Friday, April 25, 2008 01:52 PM

Top News

SpineMark CRO Creates Own Multi-Site Research Network

SpineMark CRO Management, a contract research organization (CRO) is creating a multi-site network of dedicated research centers, collaborating first with clinical investigators in Los Angeles and Denver. SpineMark CRO plans to have 20 such sites in place by the first quarter of 2009. Eventually, the company wants to have 35 centers across the U.S. and 10 outside the country.

AbCRO Opens Office in Ukraine

Sofia, Bulgaria-based, American-owned contract research organization AbCRO opened an office in Kiev, Ukraine. The opening comes just on the heels of the company’s two new offices in Russia—one in St. Petersburg and one in Moscow. The opening comes just on the heels of the company’s two new offices in Russia—one in St. Petersburg and one in Moscow.
    
Other breaking news...      

Company Profile: An interview with James McDermott, corporate development director, Quanticate

To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.